{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:48:36Z","timestamp":1761662916585,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":1579,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jmii.2011.01.035","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T01:30:56Z","timestamp":1295832656000},"page":"376-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan"],"prefix":"10.1016","volume":"44","author":[{"given":"Chi-Chang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Jung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Chun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Yao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2011.01.035_bib1","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jmii.2011.01.035_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/502158","article-title":"Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study","volume":"24","author":"Wisplinghoff","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2011.01.035_bib3","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1200\/JCO.2005.01.6378","article-title":"Length\u00a0of stay and mortality associated with febrile neutropenia among children with cancer","volume":"23","author":"Basu","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmii.2011.01.035_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10096-005-0077-8","article-title":"Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections","volume":"25","author":"Velasco","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib5","first-page":"1144","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"37","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib6","first-page":"1","article-title":"Epidemiology of bloodstream infections in patients with haemaological malignancies with and without neutropenia","volume":"27","author":"Chen","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"34","key":"10.1016\/j.jmii.2011.01.035_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00134-008-1040-9","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock","volume":"2008","author":"Dellinger","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jmii.2011.01.035_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.CCM.0000143118.41100.14","article-title":"Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review","volume":"32","author":"Bochud","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2011.01.035_bib9","first-page":"455","article-title":"Guideline for the use of antimicrobial agents in patients with febrile neutropenia in Taiwan","volume":"38","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2011.01.035_bib10","series-title":"Manual of clinical microbiology","first-page":"103","article-title":"Substrate utilization systems for the identification of bacteria and yeast","author":"Miller","year":"1995"},{"year":"2005","series-title":"Performance standards for antimicrobial susceptibility testing; 15th informational supplement. M100-S15","author":"Clinical and Laboratory Standards Institute","key":"10.1016\/j.jmii.2011.01.035_bib11"},{"key":"10.1016\/j.jmii.2011.01.035_bib12","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/JCM.02351-06","article-title":"Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control","volume":"45","author":"Brown","year":"2007","journal-title":"J Clin Microbio1"},{"year":"2005","series-title":"Tygacil (tigecycline) for injection","author":"Pharmaceuticals","key":"10.1016\/j.jmii.2011.01.035_bib13"},{"key":"10.1016\/j.jmii.2011.01.035_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/jcm.20.3.409-412.1984","article-title":"Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR 810, a fourth-generation cephalosporin, in clinical microbiology laboratories","volume":"20","author":"Jones","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2011.01.035_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0732-8893(86)90076-3","article-title":"Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media","volume":"4","author":"Jones","year":"1986","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib16","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/322646","article-title":"A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia","volume":"33","author":"Del Favero","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s100960050345","article-title":"Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia","volume":"18","author":"Gonz\u00e1lez-Barca","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/345435","article-title":"Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy","volume":"36","author":"Cordonnier","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000085623","article-title":"Bacteremia in patients with hematological malignancies","volume":"51","author":"Wang","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jmii.2011.01.035_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1473-3099(05)70164-X","article-title":"Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials","volume":"5","author":"Vardakas","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijantimicag.2007.05.022","article-title":"Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?","volume":"30","author":"Bhat","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2011.01.035_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1473-3099(02)00241-4","article-title":"Monotherapy or aminoglycoside containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis","volume":"2","author":"Furno","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.326.7399.1111","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis","volume":"326","author":"Paul","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jmii.2011.01.035_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(04)01108-9","article-title":"Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis","volume":"4","author":"Safdar","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib25","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/AAC.47.9.2756-2764.2003","article-title":"Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia","volume":"47","author":"Chamot","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.01.035_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1086\/426189","article-title":"Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections","volume":"40","author":"Burgess","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.01.035_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/dki204","article-title":"In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin","volume":"56","author":"Drago","year":"2005","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:16:24Z","timestamp":1761657384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118211000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1684118211000661"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2011.01.035","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2011.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}